Journal of Peking University(Health Sciences) >
Risk factors associated with different types of Henoch-Schönlein purpura in Tibetan patients at high altitude
Received date: 2022-08-02
Online published: 2023-10-09
Supported by
the Natural Science Foundation of Tibet Autonomous Region(XZ2021ZR-ZY06(Z))
Objective: To investigate the risk factors of different types of Henoch-Schönlein purpura (HSP) in Tibetan patients at high altitude, as to provide reference for correctly identifying high-risk patients. Methods: A retrospective study was used to analyze the 304 HSP patients admitted to Tibet Autonomous Region People's Hospital from April 2014 to March 2022. The gender, age, allergic history, family history, clinical type, laboratory indexes (hemoglobin, platelet count, eosinophil, C-reactive protein (CRP), albumin, immunoglobulin G, immunoglobulin A, complement C3 and C4) were analyzed retrospectively. Univariate and multivariate Logistic regression analysis to screen for risk factors affecting different types of HSP. Results: Renal HSP patients showed higher IgA [(9.2±1.7) g/L vs. (6.4±2.4) g/L, P=0.015], lower complement C3 [(203.3±21.6) mg/dL vs. (301.1±19.5) mg/dL, P=0.043], and complement C4 [(33.5±2.3) mg/dL vs. (53.0±7.2) mg/dL, P=0.032]. The patients with abdominal HSP showed lower levels of hemoglobin [(119.6±19.6) g/L vs. (146.6±47.3) g/L, P=0.038] and plasma albumin [24.8 (22.1, 33.9) g/L vs. 32.6 (24.6, 35.1) g/L, P=0.045]. The patients with articular HSP exhibited higher CRP [13.5 (0.2, 20.6) g/L vs. 7.5 (0.1, 15.2) g/L, P=0.036] and erythrocyte sedimentation rate (ESR) [24 (5, 40) mm/h vs. 15 (4, 30) mm/h, P=0.049]. Elevated IgA and decreased complement C4 were risk factors for renal HSP, anemia and decreased plasma albumin were risk factors for abdominal HSP, and elevated CRP was a risk factor for articular HSP. Conclusion: The clinical characteristics of different types of HSP in plateau areas were different. Patients with high IgA, low complement C4, anemia, hypoalbuminemia, and significantly elevated CRP should be highly vigilant. Early and effective intervention can improve the clinical efficacy, avoid severe development, and improve the prognosis
Hui WEI , Ci-dan-yang-zong , Yi-xi-la-mu , Bai-ma-yang-jin . Risk factors associated with different types of Henoch-Schönlein purpura in Tibetan patients at high altitude[J]. Journal of Peking University(Health Sciences), 2023 , 55(5) : 923 -928 . DOI: 10.19723/j.issn.1671-167X.2023.05.022
| 1 | Wakaki H , Ishikura K . Henoch-Sch?nlein nephritis with nephrotic state in children: Predictors of poor outcomes[J]. Pediatr Nephrol, 2012, 27 (2): 335. |
| 2 | Ueda H , Miyazaki Y , Tsuboi N , et al. Clinical and pathological characteristics of elderly Japanese patients with IgA vasculitis with nephritis: A case series[J]. Intern Med, 2019, 58 (1): 31- 38. |
| 3 | Cakici EK , Suker EDK , Ozlu SG , et al. MEFV gene mutations in children with Henoch-Sch?nlein purpura and their correlations-do mutations matter[J]. Clin Rheumatol, 2019, 38 (7): 1947- 1952. |
| 4 | Gardner-Medwin JM , Dolezalova P , Cummins C , et al. Incidence of Henoch-Sch?nlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins[J]. Lancet, 2002, 360 (9341): 1197- 1202. |
| 5 | Hetland LE , Susrud KS , Lindahl KH , et al. Henoch-Sch?nlein purpura: A literature review[J]. Acta Derm Venereol, 2017, 97 (10): 1160- 1166. |
| 6 | Wang H , Das L , Hoh SF , et al. Urinalysis monitoring in children with Henoch-Sch?nlein purpura: Is it time to revise[J]. Int J Rheum Dis, 2019, 22 (7): 1271- 1277. |
| 7 | 孙小妹, 戴亮, 孙飞扬, 等. 成都地区与川西高原地区过敏性紫癜患儿临床特征比较分析[J]. 现代预防医学, 2018, 45 (12): 2274-2276, 2287. |
| 8 | Delbet JD , Hogan J , Aoun B , et al. Clinical outcomes in children with Henoch-Sch?nlein purpura nephritis without crescents[J]. Pediatr Nephrol, 2017, 32 (7): 1193- 1199. |
| 9 | Novak J , Vu HL , Novak L , et al. Interactions of human mesangial cells with IgA and IgA-containing immune complexes[J]. Kidney Int, 2002, 62 (2): 465- 475. |
| 10 | Tabel Y , Inanc FC , Dogan DG , et al. Clinical features of children with Henoch-Sch?nlein purpura: risk factors associated with renal involvement[J]. Iran J Kidney Dis, 2012, 6 (4): 269- 274. |
| 11 | Reamy BV , Servey JT , Williams PM . Henoch-Sch?nlein purpura (IgA vasculitis): Rapid evidence review[J]. Am Fam Physician, 2020, 102 (4): 229- 233. |
| 12 | Audemard-Verger A , Pillebout E , Guillevin L , et al. IgA vasculitis (Henoch-Sh?nlein purpura) in adults: Diagnostic and therapeutic aspects[J]. Autoimmun Rev, 2015, 14 (7): 579- 585. |
| 13 | 央珍, 郭琳, 熊昊, 等. 西藏高原地区儿童过敏性紫癜的临床分析[J]. 中国当代儿科杂志, 2014, 16 (12): 1231- 1235. |
| 14 | 曾传文, 格桑德吉, 达瓦曲珍, 等. 高原藏族儿童过敏性紫癜相关文献因素分析[J]. 中华危重病急救医学, 2019, 31 (6): 742- 745. |
| 15 | Tan J , Tang Y , Xu Y , et al. The clinicopathological characteristics of Henoch-Sch?nlein purpura nephritis with presentation of nephrotic syndrome[J]. Kidney Blood Press Res, 2019, 44 (4): 754- 764. |
| 16 | Buscatti IM , Casella BB , Aikawa NE , et al. Henoch-Sch?nlein purpura nephritis: Initial risk factors and outcomes in a Latin American tertiary center[J]. Clin Rheumatol, 2018, 37 (5): 1319- 1324. |
| 17 | Karadag SG , Tanatar A , Sonmez HE , et al. The clinical spectrum of Henoch-Sch?nlein purpura in children: A single-center study[J]. Clin Rheumatol, 2019, 38 (6): 1707- 1714. |
| 18 | 魏慧, 罗增, 次旦央宗, 等. 高原地区不同海拔高度腹型过敏性紫癜患者临床特征分析[J]. 北京大学学报(医学版), 2021, 53 (6): 1072- 1077. |
/
| 〈 |
|
〉 |